COH.AX - Cochlear Limited

ASX - ASX Delayed price. Currency in AUD
+0.15 (+0.06%)
At close: 04:10PM AEST
Stock chart is not supported by your current browser
Previous close245.00
Bid245.15 x 10000
Ask245.35 x 3400
Day's range244.87 - 248.00
52-week range184.62 - 253.36
Avg. volume144,701
Market cap16.126B
Beta (5Y monthly)0.45
PE ratio (TTM)61.44
Earnings dateN/A
Forward dividend & yield3.10 (1.27%)
Ex-dividend date21 Mar 2023
1y target estN/A
  • PR Newswire

    Hearing loss in global spotlight as technology and research leaders collaborate to tackle rising impact, and experts unite to demystify care

    According to the World Health Organization (WHO), the number of people living with hearing loss is set to reach 2.5 billion by 2050.1 Now, leading technology companies, researchers, and people living with hearing loss are coming together to tackle its rising impact.

  • PR Newswire

    Cochlear announces 2023 winners of annual scholarships

    Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 21st annual Graeme Clark, the 12th annual Anders Tjellström, and 1st annual Vocational Scholarships. The Academic Scholarships are named after two pioneers of the hearing implant industry and recognize Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and dem

  • PR Newswire

    Cochlear announces audio streaming from Amazon Fire TV devices for hearing implant users

    Ahead of International Cochlear Implant Day (February 25, 2023), Cochlear is announcing that it will now offer Audio Streaming for Hearing Aids (ASHA) support on compatible Fire TV devices for people living with hearing implant technology. The advancement represents the first time that a smart TV device will stream sound directly to a hearing implant sound processor.

  • PR Newswire

    FDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology

    Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor. The Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry. 1-3 It is also the world's first cochlear implant sound processor ready to provide direct audio connectivity to everyday consumer electronics using the next generation LE Audio